Medicines (Labelling of Chinese Proprietary Medicines) (Amendment) Regulations 2016

Status:

Published in Subsidiary Legislation Supplement
on 31 Oct 2016

No. S 546

Medicines Act

(CHAPTER 176)

Medicines (Labelling of
Chinese Proprietary Medicines)
(Amendment) Regulations 2016

In exercise of the powers conferred by sections 44, 45, 46 and 52 of the Medicines Act, the Minister for Health makes the following Regulations:

Citation and commencement

1. These Regulations are the Medicines (Labelling of Chinese Proprietary Medicines) (Amendment) Regulations 2016 and come into operation on 1 November 2016.

New regulation 2A

2. The Medicines (Labelling of Chinese Proprietary Medicines) Regulations (Rg 13) are amended by inserting, immediately after regulation 2, the following regulation:

“Scope of Regulations

2A. These Regulations do not apply to any Chinese proprietary medicine that is clinical research material as defined in regulation 2 of the Medicines (Medicinal Products as Clinical Research Materials) Regulations 2016 (G.N. No. S 336/2016).”.

Deletion of regulation 4

3. Regulation 4 of the Medicines (Labelling of Chinese Proprietary Medicines) Regulations is deleted.

[G.N. No. S 315/2005]

Made on 25 October 2016.

CHAN HENG KEE

Permanent Secretary,
Ministry of Health,
Singapore.

[HSA/LPPD/711:12/72-000; AG/LEGIS/SL/176/2015/5 Vol. 1]

Search within Legislation